MINNEAPOLIS, July 31, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading vertically integrated cannabis company and agricultural markets platform, today announced that it entered into four separate definitive Securities Purchase Agreements with each of FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC (collectively, the “Ohio Entities”) and certain other parties, to acquire all of the issued and outstanding membership interests of the four Ohio Entities and certain of their respective subsidiaries (collectively, the “Ohio Transactions”), subject to receipt of all required regulatory approvals and customary closing conditions.